BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25987041)

  • 1. Arsenic Trioxide Inhibits Cell Growth and Invasion via Down- Regulation of Skp2 in Pancreatic Cancer Cells.
    Gao JK; Wang LX; Long B; Ye XT; Su JN; Yin XY; Zhou XX; Wang ZW
    Asian Pac J Cancer Prev; 2015; 16(9):3805-10. PubMed ID: 25987041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
    Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
    Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells.
    Zhang S; Ma C; Pang H; Zeng F; Cheng L; Fang B; Ma J; Shi Y; Hong H; Chen J; Wang Z; Xia J
    Biochem Biophys Res Commun; 2016 Jan; 469(1):55-61. PubMed ID: 26592661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W; Adachi M; Zhang R; Zhou J; Zhu D
    Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells.
    Wang L; Ye X; Cai X; Su J; Ma R; Yin X; Zhou X; Li H; Wang Z
    Oncotarget; 2015 Jul; 6(20):18027-37. PubMed ID: 26046466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
    Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
    Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells.
    Li X; Ding X; Adrian TE
    Cancer Invest; 2004; 22(3):389-400. PubMed ID: 15493360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic Trioxide Induces Apoptosis and Incapacitates Proliferation and Invasive Properties of U87MG Glioblastoma Cells through a Possible NF-κB-Mediated Mechanism.
    Ghaffari SH; Yousefi M; Dizaji MZ; Momeny M; Bashash D; Zekri A; Alimoghaddam K; Ghavamzadeh A
    Asian Pac J Cancer Prev; 2016; 17(3):1553-64. PubMed ID: 27039805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANXA1 silencing increases the sensitivity of cancer cells to low-concentration arsenic trioxide treatment by inhibiting ERK MAPK activation.
    Zhang X; Li X; Li X; Zheng L; Lei L
    Tumori; 2015; 101(4):360-7. PubMed ID: 25983101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide inhibits cell growth and induces apoptosis through inactivation of notch signaling pathway in breast cancer.
    Xia J; Li Y; Yang Q; Mei C; Chen Z; Bao B; Ahmad A; Miele L; Sarkar FH; Wang Z
    Int J Mol Sci; 2012; 13(8):9627-9641. PubMed ID: 22949821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
    Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma.
    Lang M; Wang X; Wang H; Dong J; Lan C; Hao J; Huang C; Li X; Yu M; Yang Y; Yang S; Ren H
    Cancer Lett; 2016 Aug; 378(2):87-96. PubMed ID: 27212442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia.
    Lam HK; Li K; Chik KW; Yang M; Liu VC; Li CK; Fok TF; Ng PC; Shing MM; Chuen CK; Yuen PM
    Int J Oncol; 2005 Aug; 27(2):537-45. PubMed ID: 16010437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines.
    Gu J; Zhu X; Li Y; Dong D; Yao J; Lin C; Huang K; Hu H; Fei J
    Med Oncol; 2011 Mar; 28(1):211-8. PubMed ID: 20143188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24.
    Cao Y; Yu SL; Wang Y; Guo GY; Ding Q; An RH
    Tumour Biol; 2011 Feb; 32(1):179-88. PubMed ID: 20857258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2.
    Wu X; Shi J; Wu Y; Tao Y; Hou J; Meng X; Hu X; Han Y; Jiang W; Tang S; Zangari M; Tricot G; Zhan F
    Cancer Biol Ther; 2010 Dec; 10(11):1201-14. PubMed ID: 20953137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide targets miR-125b in glioma cells.
    Chen S; Zhu L; Huang J; Cai Y; Lu X; Yang Q; Wu Q; Chen C; Wang Z
    Curr Pharm Des; 2014; 20(33):5354-61. PubMed ID: 24479808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of ID2 antagonizes arsenic trioxide-induced antitumor effects in cancer cells.
    Zhang X; Lv C; Du B; Ma X; Guan J; Gao S; Li X; Zheng L; Lei L
    Tumori; 2014; 100(3):352-7. PubMed ID: 25076250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide.
    Cui L; Gao B; Cao Z; Chen X; Zhang S; Zhang W
    Mol Med Rep; 2016 Mar; 13(3):2032-8. PubMed ID: 26781180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The conformation change of Bcl-2 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in SGC7901 human gastric cancer cells.
    Zheng Y; Zhou M; Ye A; Li Q; Bai Y; Zhang Q
    World J Surg Oncol; 2010 Apr; 8():31. PubMed ID: 20403207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.